Definitive diagnosis* |
Male patient with less than 2% CD19+ B cells and at least one of the following: |
|
|
|
|
Probable diagnosis* |
Male patient with less than 2% CD19+ B cells in whom all of the following are positive: |
|
|
|
|
Possible diagnosis* |
Male patient with less than 2% CD19+ B cells in whom other causes of hypogammaglobulinemia have been excluded and at least one of the following is positive: |
|
|
|
BtK: Bruton tyrosine kinase; CD: cluster of differentiation; IgA: immunoglobulin A; IgG: immunoglobulin G; IgM: immunoglobulin M; mRNA: messenger ribonucleic acid; SD: standard deviation.
* Patients with a definitive or probable diagnosis are assumed to have a greater than 98 and 85% probability, respectively, that in 20 years they will still have the same diagnosis. Patients with a possible diagnosis are those that have some, but not all, of the characteristic clinical or laboratory findings of a particular disorder.